Björn Nashan

17.9k total citations · 3 hit papers
377 papers, 12.8k citations indexed

About

Björn Nashan is a scholar working on Surgery, Transplantation and Hepatology. According to data from OpenAlex, Björn Nashan has authored 377 papers receiving a total of 12.8k indexed citations (citations by other indexed papers that have themselves been cited), including 174 papers in Surgery, 161 papers in Transplantation and 110 papers in Hepatology. Recurrent topics in Björn Nashan's work include Renal Transplantation Outcomes and Treatments (157 papers), Organ Transplantation Techniques and Outcomes (130 papers) and Liver Disease and Transplantation (62 papers). Björn Nashan is often cited by papers focused on Renal Transplantation Outcomes and Treatments (157 papers), Organ Transplantation Techniques and Outcomes (130 papers) and Liver Disease and Transplantation (62 papers). Björn Nashan collaborates with scholars based in Germany, United States and China. Björn Nashan's co-authors include Josep M. Grinyó, Henrik Ekberg, Philip F. Halloran, Flavio Vincenti, Yves Vanrenterghem, Hans J. Schlitt, Hélio Tedesco‐Silva, Michael P. Manns, Christian Hugo and Š Vı́tko and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Nature Communications.

In The Last Decade

Björn Nashan

361 papers receiving 12.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Reduced Exposure to Calcineurin Inhibitors in Renal Transplantation

2007 1.4k citations Björn Nashan, Philip F. Halloran et al. profile →
Costimulation Blockade with Belatacept in Renal Transplantation

2005 628 citations Flavio Vincenti, Björn Nashan et al. profile →
Randomised trial of basiliximab versus placebo for control of acute cellular rejection in renal allograft recipients

1997 556 citations Björn Nashan et al. profile →

Peers

Countries citing papers authored by Björn Nashan

Since Specialization

Citations

This map shows the geographic impact of Björn Nashan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Björn Nashan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Björn Nashan more than expected).

Fields of papers citing papers by Björn Nashan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Björn Nashan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Björn Nashan. The network helps show where Björn Nashan may publish in the future.

Co-authorship network of co-authors of Björn Nashan

This figure shows the co-authorship network connecting the top 25 collaborators of Björn Nashan. A scholar is included among the top collaborators of Björn Nashan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Björn Nashan. Björn Nashan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Proteomic Landscape of Colorectal Cancer Derived Liver Metastasis Reveals Three Distinct Phenotypes With Specific Signaling and Enhanced Survival 2025 ·Molecular & Cellular Proteomics ·(unknown), N. V. Popova, (unknown), Daniel J. Smit, (unknown), Matthew J. McKay, Thomas J. Hugh, Kerstin A. David, Hartmut Juhl, (unknown), Jens U. Marquardt, Björn Nashan, Hartmut Schlüter, Mark P. Molloy, Manfred Jücker	0
2	Diagnosis and Treatment of Hepatic Hematoma After Liver Transplantation in a Timely Manner 2024 ·Transplantation Proceedings ·Ning Wang, Zebin Zhu, Hao Zheng, (unknown), Xiaodong Yuan, Xuefeng Li, Zhijun Xu, Jiwei Qin, Wei Wu, Jizhou Wang, D S Lu, Weiyong Liu, Lianxin Liu, Shugeng Zhang, Björn Nashan	0
3	Incidence and Treatment of Arginine Vasopressin Deficiency (Central Diabetes Insipidus) in the Setting of Brain Death and Associations with Renal Function and Hemodynamics in Organ Donors 2024 ·Journal of Clinical Medicine ·Melanie Weiß, (unknown), Volker Thieme, Karin Hochmuth, Dominik Michalski, Björn Nashan, Hans‐Michael Tautenhahn, Robert Werdehausen, (unknown)	1
4	Human Leucocyte Antigen–Matching Can Improve Long Term Outcome of Renal Allografts from Donors Older Than 75 Years 2023 ·Transplantation Proceedings ·Martina Koch, Daniel Zecher, Kai Lopau, Julia Weinmann‐Menke, (unknown), Björn Nashan, Ulrich Wenzel, Bernhard Banas, Martin Zeier, Friedrich Thaiss, Claudia Sommerer	1
5	C20orf204, a hepatocellular carcinoma-specific protein interacts with nucleolin and promotes cell proliferation 2021 ·Oncogenesis ·(unknown), Doan Duy Hai Tran, (unknown), (unknown), Björn Nashan, Martina Koch, Teruko Tamura	26
6	Impact of TBX21, GATA3, and FOXP3 gene polymorphisms on acute cellular rejection after liver transplantation 2019 ·HLA ·Hansjörg Thude, (unknown), Martina Sterneck, Björn Nashan, Martina Koch	5
7	Protein tyrosine phosphatase non‐receptor type 22 (PTPN22) gene polymorphisms in liver transplant donors and impact on acute cellular liver transplant rejection 2019 ·HLA ·Hansjörg Thude, (unknown), Matthias Marget, Sven Peine, Björn Nashan, Martina Koch	1
8	Structured introduction of retroperitoneoscopic donor nephrectomy provides a high level of safety and reduces the physical burden for the donor compared to an anterior mini incision: A cohort study 2019 ·International Journal of Surgery ·Martina Koch, Sylvia Kroencke, Jun Li, Christian Wiessner, Björn Nashan	2
9	Limited impact of pre-existing donor specific HLA-antibodies (DSA) on long term allograft survival after first adult liver transplantation 2018 ·Human Immunology ·Martina Koch, Matthias Marget, Martina Sterneck, Lutz Fischer, Hansjörg Thude, Björn Nashan	7
10	Dual antibody induction and de novo use of everolimus enable low-dose tacrolimus with early corticosteroid withdrawal in simultaneous pancreas-kidney transplantation 2018 ·Transplant Immunology ·Jun Li, Martina Koch, (unknown), Katja Kloth, (unknown), (unknown), Franz Rinninger, Friedrich Thaiss, Amit Gulati, Uta Herden, E. Achilles, Lutz Fischer, Björn Nashan	4
11	Graft-derived cell-free DNA, a noninvasive early rejection and graft damage marker in liver transplantation: A prospective, observational, multicenter cohort study 2017 ·PLoS Medicine ·Ekkehard Schütz, Anna Fischer, Julia Beck, Markus Harden, Martina Koch, Tilo Wuensch, Martin Stockmann, Björn Nashan, Otto Kollmar, Johannes Matthaei, Philipp Kanzow, Philip D. Walson, Jürgen Brockmöller, Michael Oellerich	148
12	The killer cell lectin‐like receptor B1 (KLRB1) 503T>C polymorphism (rs1135816) and acute rejection after liver transplantation 2017 ·HLA ·Hansjörg Thude, (unknown), Martina Sterneck, Jürgen Klempnauer, Björn Nashan, Reinhard Schwinzer, Martina Koch	3
13	Effects of FTY720 on peripheral blood lymphocytes and graft infiltrating cells in a rat model of chronic renal allograft rejection 2016 ·Transplant Immunology ·Martina Koch, (unknown), Björn Nashan	4
14	Surgical complications after peritoneal dialysis catheter implantation depend on children's weight 2015 ·Journal of Pediatric Surgery ·(unknown), (unknown), Markus J. Kemper, Björn Nashan, Martina Koch	12
15	Mental and Physical Quality of Life in Actual Living Liver Donors Versus Potential Living Liver Donors 2009 ·Liver Transplantation ·Karl‐Heinz Schulz, Sylvia Kroencke, Mingo Beckmann, Silvio Nadalin, Andreas Paul, Lutz Fischer, Björn Nashan, Wolfgang Senf, Yeşim Erim	37
16	Belatacept (LEA29Y) as part of a CNI-free regimen in recipients of renal allografts with higher risk of poor long-term function and graft loss: Comparison with cyclosporine A 2005 ·American Journal of Transplantation ·(unknown), Philip F. Halloran, Yves Vanrenterghem, Thomas C. Pearson, Björn Nashan, Kristina Sennvik, Nancy Krieger, B Charpentier	5
17	Liver transplantation using organs from donors older than 60 years 2004 ·Transplant International ·Michael Neipp, Hueseyin Bektas, (unknown), (unknown), Thomas Becker, J. Klempnauer, Björn Nashan	13
18	Liver transplantation using organs from donors older than 60 years 2004 ·Transplant International ·Michael Neipp, Hueseyin Bektas, (unknown), (unknown), Thomas Becker, J. Klempnauer, Björn Nashan	14
19	The economics of basiliximab (Simulect) in preventing acute rejection in renal transplantation. 2002 ·PubMed ·J. Chilcott, Michael Holmes, Stephen J. Walters, R. Akehurst, Björn Nashan	16
20	RESULTS OF 3-YEAR PHASE III CLINICAL TRIALS WITH DACLIZUMAB PROPHYLAXIS FOR PREVENTION OF ACUTE REJECTION AFTER RENAL TRANSPLANTATION1 2001 ·Transplantation ·Ginny L. Bumgardner, Ian R. Hardie, Robert W. Johnson, Amy Lin, Björn Nashan, Mark D. Pescovitz, Eleanor L. Ramos, Flavio Vincenti	88

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact